Literature DB >> 29512888

The past, present and future of service delivery in genetic counseling: Keeping up in the era of precision medicine.

Katie Stoll1, Shobana Kubendran2, Stephanie A Cohen3.   

Abstract

Precision medicine aims to approach disease treatment and prevention with consideration of the variability in genes, environment, and lifestyle for each person. This focus on the individual is also key to the practice of genetic counseling, whereby foundational professional values prioritize informed and autonomous patient decisions regarding their genetic health. Genetic counselors are ideally suited to help realize the goals of the precision medicine. However, a limited genetic counseling workforce at a time in which there is a rapidly growing need for services is challenging the balance of supply and demand. This article provides historical context to better understand what has informed traditional models of genetic counseling and considers some of the current forces that require genetic counselors to adapt their practice. New service delivery models can improve access to genetic healthcare by overcoming geographical barriers, allowing genetic counselors to see a higher volume of patients and supporting other healthcare providers to better provide genetic services to meet the needs of their patients. Approaches to genetic counseling service delivery are considered with a forward focus to the challenges and opportunities that lie ahead for genetic counselors in this age of precision health.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  genetic counseling; precision medicine; service delivery models; workforce

Mesh:

Year:  2018        PMID: 29512888     DOI: 10.1002/ajmg.c.31602

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  32 in total

1.  Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium.

Authors:  Channing J Paller; Emmanuel S Antonarakis; Tomasz M Beer; Hala T Borno; Maria I Carlo; Daniel J George; Julie N Graff; Shilpa Gupta; Elisabeth I Heath; Celestia S Higano; Rana R McKay; Alicia K Morgans; Akash Patnaik; Daniel P Petrylak; Matthew B Rettig; Charles J Ryan; Mary-Ellen Taplin; Young E Whang; Jacob Vinson; Heather H Cheng; Veda N Giri
Journal:  Clin Genitourin Cancer       Date:  2019-04-18       Impact factor: 2.872

2.  Developing a Process for Returning Medically Actionable Genomic Variants to Latino Patients in a Federally Qualified Health Center.

Authors:  Gabriel Q Shaibi; Iftikhar J Kullo; Davinder P Singh; Richard R Sharp; Eleanna De Filippis; Idali Cuellar; Valentina Hernandez; Sharon Levey; Carmen Radecki Breitkopf; Janet E Olson; James R Cerhan; Lawrence J Mandarino; Stephen N Thibodeau; Noralane M Lindor
Journal:  Public Health Genomics       Date:  2018-12-06       Impact factor: 2.000

3.  Trends in BRCA Test Utilization in an Integrated Health System, 2005-2015.

Authors:  Sarah Knerr; Erin J A Bowles; Kathleen A Leppig; Diana S M Buist; Hongyuan Gao; Karen J Wernli
Journal:  J Natl Cancer Inst       Date:  2019-08-01       Impact factor: 13.506

4.  Assessing the Psychological Impact of Genetic Susceptibility Testing.

Authors:  J Scott Roberts
Journal:  Hastings Cent Rep       Date:  2019-05       Impact factor: 2.683

5.  The Impact of Genetic Counseling Educational Tools on Patients' Knowledge of Molecular Testing Terminology.

Authors:  Brianna A McDaniels; Rachel S Hianik; Cecelia Bellcross; Walid L Shaib; Jeffrey Switchenko; Margie D Dixon; Jane L Meisel; Keerthi Gogineni; Rebecca D Pentz
Journal:  J Cancer Educ       Date:  2020-10       Impact factor: 2.037

Review 6.  Practical Considerations and Challenges for Germline Genetic Testing in Patients With Prostate Cancer: Recommendations From the Germline Genetics Working Group of the PCCTC.

Authors:  Brittany M Szymaniak; Lauren A Facchini; Veda N Giri; Emmanuel S Antonarakis; Tomasz M Beer; Maria I Carlo; Daniel C Danila; Mallika Dhawan; Daniel George; Julie N Graff; Shilpa Gupta; Elisabeth Heath; Celestia S Higano; Glenn Liu; Ana M Molina; Channing J Paller; Akash Patnaik; Daniel P Petrylak; Zachery Reichert; Matthew B Rettig; Charles J Ryan; Mary-Ellen Taplin; Jake Vinson; Young E Whang; Alicia K Morgans; Heather H Cheng; Rana R McKay
Journal:  JCO Oncol Pract       Date:  2020-09-28

7.  Genetic counselors on the frontline of precision health.

Authors:  Michael J Bamshad; Pilar L Magoulas; Karin M Dent
Journal:  Am J Med Genet C Semin Med Genet       Date:  2018-03-26       Impact factor: 3.908

8.  Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines.

Authors:  Piper Nicolosi; Elisa Ledet; Shan Yang; Scott Michalski; Brandy Freschi; Erin O'Leary; Edward D Esplin; Robert L Nussbaum; Oliver Sartor
Journal:  JAMA Oncol       Date:  2019-04-01       Impact factor: 31.777

9.  A pilot randomized trial of an educational intervention to increase genetic counseling and genetic testing among Latina breast cancer survivors.

Authors:  Claire C Conley; Eida M Castro-Figueroa; Laura Moreno; Julie Dutil; Jennifer D García; Carolina Burgos; Charité Ricker; Jongphil Kim; Kristi D Graves; Kimlin Tam Ashing; Gwendolyn P Quinn; Hatem Soliman; Susan T Vadaparampil
Journal:  J Genet Couns       Date:  2020-09-16       Impact factor: 2.537

10.  Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019.

Authors:  Veda N Giri; Karen E Knudsen; William K Kelly; Heather H Cheng; Kathleen A Cooney; Michael S Cookson; William Dahut; Scott Weissman; Howard R Soule; Daniel P Petrylak; Adam P Dicker; Saud H AlDubayan; Amanda E Toland; Colin C Pritchard; Curtis A Pettaway; Mary B Daly; James L Mohler; J Kellogg Parsons; Peter R Carroll; Robert Pilarski; Amie Blanco; Ashley Woodson; Alanna Rahm; Mary-Ellen Taplin; Thomas J Polascik; Brian T Helfand; Colette Hyatt; Alicia K Morgans; Felix Feng; Michael Mullane; Jacqueline Powers; Raoul Concepcion; Daniel W Lin; Richard Wender; James Ryan Mark; Anthony Costello; Arthur L Burnett; Oliver Sartor; William B Isaacs; Jianfeng Xu; Jeffrey Weitzel; Gerald L Andriole; Himisha Beltran; Alberto Briganti; Lindsey Byrne; Anne Calvaresi; Thenappan Chandrasekar; David Y T Chen; Robert B Den; Albert Dobi; E David Crawford; James Eastham; Scott Eggener; Matthew L Freedman; Marc Garnick; Patrick T Gomella; Nathan Handley; Mark D Hurwitz; Joseph Izes; R Jeffrey Karnes; Costas Lallas; Lucia Languino; Stacy Loeb; Ana Maria Lopez; Kevin R Loughlin; Grace Lu-Yao; S Bruce Malkowicz; Mark Mann; Patrick Mille; Martin M Miner; Todd Morgan; Jose Moreno; Lorelei Mucci; Ronald E Myers; Sarah M Nielsen; Brock O'Neil; Wayne Pinover; Peter Pinto; Wendy Poage; Ganesh V Raj; Timothy R Rebbeck; Charles Ryan; Howard Sandler; Matthew Schiewer; E Michael D Scott; Brittany Szymaniak; William Tester; Edouard J Trabulsi; Neha Vapiwala; Evan Y Yu; Charnita Zeigler-Johnson; Leonard G Gomella
Journal:  J Clin Oncol       Date:  2020-06-09       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.